Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
Condition: Measles Intervention: Device: SMS, telephone interview or diary card Sponsor: Dilla University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2023 Category: Research Source Type: clinical trials
